Literature DB >> 11850838

Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.

Risto Ala-aho1, Reidar Grénman, Prem Seth, Veli-Matti Kähäri.   

Abstract

Squamous cell carcinomas (SCCs) of the head and neck are characterized by high tendency to invade locally and metastasize to lymph nodes. SCC cells express several matrix metalloproteinases (MMPs) and they often harbor mutations in p53 tumor suppressor gene. Collagenase-3 (MMP-13) is specifically expressed by tumor cells of SCCs and it apparently plays an important role in their invasion and metastasis. We used adenoviral gene delivery to examine the effect of wild-type p53 on MMP-13 expression in four head and neck SCC cell lines with mutated p53. Adenoviral delivery of p53 resulted in potent inhibition in production of proMMP-13 (by 71 to 92%) and collagenase-1 (MMP-1) (by 27 to 93%) by all cell lines in 24 h, whereas production of gelatinase-A (MMP-2) and gelatinase-B (MMP-9) was not altered. Adenoviral expression of p53 also suppressed invasion of SCC cells through Matrigel by 35%. Expression of cyclin-dependent kinase inhibitor p21(Waf1/Cip1) was induced 24 h after p53 gene delivery in all SCC cell lines, except one, which lacked detectable p21(Waf1/Cip1) expression. Number of viable cells was not altered and no apoptotic cells were seen 24 h after p53 delivery. These results show, that wild-type p53 potently inhibits expression of MMP-13 and MMP-1 by SCC cells independently of its pro-apoptotic effect. Together these results indicate, that p53 exerts a bi-phasic tumor suppressor effect on SCC cells: inhibition of cell invasion followed by induction of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850838     DOI: 10.1038/sj.onc.1205198

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  HOXA11 promotes fibroblast proliferation and regulates p53 in uterosacral ligaments.

Authors:  Kathleen A Connell; Marsha K Guess; Heidi W Chen; Tara Lynch; Richard Bercik; Hugh S Taylor
Journal:  Reprod Sci       Date:  2009-04-16       Impact factor: 3.060

2.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer.

Authors:  Junfei Xu; Feiran Wang; Haiyan Jiang; Yasu Jiang; Jinpeng Chen; Jun Qin
Journal:  J Gastrointest Surg       Date:  2015-05-29       Impact factor: 3.452

Review 4.  p53 regulates cytoskeleton remodeling to suppress tumor progression.

Authors:  Keigo Araki; Takahiro Ebata; Alvin Kunyao Guo; Kei Tobiume; Steven John Wolf; Keiko Kawauchi
Journal:  Cell Mol Life Sci       Date:  2015-07-24       Impact factor: 9.261

Review 5.  Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.

Authors:  Shun Li; David Mark Pritchard; Lu-Gang Yu
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

6.  The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response.

Authors:  M Leech; J R Xue; A Dacumos; P Hall; L Santos; Y Yang; M Li; A R Kitching; E F Morand
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

7.  MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.

Authors:  Nikola Holtkamp; Isis Atallah; Ali-Fuat Okuducu; Jana Mucha; Christian Hartmann; Victor-F Mautner; Reinhard E Friedrich; Christian Mawrin; Andreas von Deimling
Journal:  Neoplasia       Date:  2007-08       Impact factor: 5.715

Review 8.  Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.

Authors:  Xiao-Feng Sun; Hong Zhang
Journal:  Mol Cancer       Date:  2006-10-06       Impact factor: 27.401

9.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells.

Authors:  M Cohen; C Wuillemin; O Irion; P Bischof
Journal:  Hum Reprod       Date:  2008-07-16       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.